Mulmit

Processa Pharmaceuticals, Inc.Processa Pharmaceuticals, Inc.

PCSA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2022-12-310-27,525,431-27,424,229-34.05
2021-12-310-12,133,543-11,427,534

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-08Ng George KChief Executive Officer1,600
2026-08-08Ng George KChief Executive Officer1,600
2026-07-28GUJRATHI SHEILA70,812
2026-07-28GUJRATHI SHEILA12,311
2026-07-26Yorke Justin W33,500
2026-07-26SKIBSTED RUSSELLChief Financial Officer11,883
2026-07-26Pannu Geraldine33,500
2026-07-26Ng George KChief Executive Officer9,384
2026-07-26Neal James R62,221
2026-07-26Lin PatrickChief Business - Strategy Off8,450
2026-07-26Guy WendyChief Administrative Officer9,450
2026-07-26Baluch Khoso33,500

8-K events

FiledItems
2026-08-04Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-07-29Entry into a material agreement · Termination of a material agreement · Completed acquisition or disposition of assets · Unregistered sales of equity securities · Officer or director change · Amendments to charter or bylaws · Regulation FD disclosure · Financial statements and exhibits
2026-04-30Officer or director change · Financial statements and exhibits
2026-02-19Termination of a material agreement · Financial statements and exhibits
2026-01-07Other events · Financial statements and exhibits
2025-12-15Material modification to rights of security holders · Amendments to charter or bylaws · Financial statements and exhibits
2025-09-16Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2025-09-12Submission of matters to a vote · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…